BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32632664)

  • 1. CD66b
    Horzum U; Yoyen-Ermis D; Taskiran EZ; Yilmaz KB; Hamaloglu E; Karakoc D; Esendagli G
    Cancer Immunol Immunother; 2021 Jan; 70(1):75-87. PubMed ID: 32632664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
    Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
    Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
    [No Abstract]   [Full Text] [Related]  

  • 3. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.
    Poschke I; Mougiakakos D; Hansson J; Masucci GV; Kiessling R
    Cancer Res; 2010 Jun; 70(11):4335-45. PubMed ID: 20484028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
    Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
    Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).
    Soler DC; Kerstetter-Fogle A; Young AB; Rayman P; Finke JH; Debanne SM; Cooper KD; Barnholtz-Sloan J; Sloan AE; McCormick TS
    Mol Immunol; 2022 Feb; 142():1-10. PubMed ID: 34953280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of CD10
    Fraccarollo D; Neuser J; Möller J; Riehle C; Galuppo P; Bauersachs J
    Elife; 2021 Jul; 10():. PubMed ID: 34289931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.
    Mao Y; Poschke I; Wennerberg E; Pico de Coaña Y; Egyhazi Brage S; Schultz I; Hansson J; Masucci G; Lundqvist A; Kiessling R
    Cancer Res; 2013 Jul; 73(13):3877-87. PubMed ID: 23633486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Toyoda M; Takahashi K; Yamamoto T; Masuyama K
    Cancer Sci; 2012 Jun; 103(6):976-83. PubMed ID: 22360618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vemurafenib reverses immunosuppression by myeloid derived suppressor cells.
    Schilling B; Sucker A; Griewank K; Zhao F; Weide B; Görgens A; Giebel B; Schadendorf D; Paschen A
    Int J Cancer; 2013 Oct; 133(7):1653-63. PubMed ID: 23526263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
    Burbano C; Vasquez G; Rojas M
    Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded CD14
    Zhang R; Shi J; Zhang R; Ni J; Habtezion A; Wang X; Hu G; Xue J
    J Immunol; 2019 May; 202(9):2578-2584. PubMed ID: 30894427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
    Yuan XK; Zhao XK; Xia YC; Zhu X; Xiao P
    J Int Med Res; 2011; 39(4):1381-91. PubMed ID: 21986138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
    Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
    Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
    Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
    Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
    Du J; Sun X; Song Y
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
    Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
    Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients.
    Marini O; Spina C; Mimiola E; Cassaro A; Malerba G; Todeschini G; Perbellini O; Scupoli M; Carli G; Facchinelli D; Cassatella M; Scapini P; Tecchio C
    Oncotarget; 2016 May; 7(19):27676-88. PubMed ID: 27050283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer.
    Trellakis S; Bruderek K; Hütte J; Elian M; Hoffmann TK; Lang S; Brandau S
    Innate Immun; 2013 Jun; 19(3):328-36. PubMed ID: 23160385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.